Blood Test Performs as Well as Tissue Biopsy in Characterizing Prostate Cancer, Study Finds

Blood Test Performs as Well as Tissue Biopsy in Characterizing Prostate Cancer, Study Finds
A blood test may one day replace tumor tissue sampling for patients with prostate cancer, as research shows that nearly 90 percent of a tumor’s genetic features can be detected in the blood. Such blood biopsies may make it easier for physicians to choose treatment, and monitor a patient for disease progression and treatment response,

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

  1. Alan Kousen says:

    If, as this implies, can effectively track PCa cancer DNA, then shouldn’t it be useful as a tool to track effectiveness for those of us whoa have had treatment? Looking at PSA numbers needs to be replaced with a REAL test that detects PCa cells.

Leave a Comment

Your email address will not be published. Required fields are marked *